Evaxion Announces Expansion Of AI-Immunology Platform Into Autoimmune Diseases, Begins Experimental Testing Of Tolerogenic Vaccine And Autoantibody Binder Concepts; Initial Data Due At PEGS Europe November 18

Loading news article.

Evaxion Announces Expansion Of AI-Immunology Platform Into Autoimmune Diseases, Begins Experimental Testing Of Tolerogenic Vaccine And Autoantibody Binder Concepts; Initial Data Due At PEGS Europe November 18 | WAPE

Evaxion Announces Expansion Of AI-Immunology Platform Into Autoimmune Diseases, Begins Experimental Testing Of Tolerogenic Vaccine And Autoantibody Binder Concepts; Initial Data Due At PEGS Europe November 18

Article summary

Related companies

Analyzed by WAPE AI.

Comments —